QGEN Qiagen NV
Company profile
Ticker
QGEN
Exchange
Employees
Incorporated in
Location
Fiscal year end
Industry (SEC)
SEC CIK
Calendar
6 Mar 19
21 Jul 19
31 Dec 19
News
Company financial data Financial data
| Annual (USD) | Dec 18 | Dec 17 | Dec 16 | Dec 15 | |
|---|---|---|---|---|---|
| Revenue | 1.5B | 1.42B | 1.34B | 1.28B | |
| Net income | 190.38M | 40.39M | 80.4M | 130.15M | |
| Diluted EPS | 0.82 | 0.17 | 0.34 | 0.55 | |
| Net profit margin | 12.68% | 2.85% | 6.01% | 10.16% | |
| Operating income | 266.58M | 153.42M | 98.83M | 179.5M | |
| Net change in cash | 501.37M | 218.53M | 149.17M | -102.66M | |
| Cash on hand | 1.16B | 657.71M | 439.18M | 290.01M | |
| Cost of revenue | 500.89M | 494.98M | 493.34M | 454.33M |
Financial data from Qiagen earnings reports
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
AACR, Academy, alpelisib, anonymized, antimicrobial, anytime, ARESdb, ASH, Barcelona, BIOSCIENCE, Boehringer, Brexit, cardiovascular, carrier, chemotherapy, circumstance, clean, compensatory, consortia, constrained, contemporary, correct, customizable, cybersecurity, cystic, de, depict, disaggregate, disaggregation, disregarded, divergent, diversified, Diversifying, DNeasy, Earth, editing, Ellume, epidermal, expedient, FastSelect, feed, Fidelio, formula, Formulatrix, fraudulent, fungal, GBS, gonorrhoeae, Hamilton, healthy, hereof, Hodgkin, hormone, immature, immunotherapy, Ingelheim, Interbank, interface, invoice, invoiced, invoicing, IVDR, Leipzig, LIAISON, London, LungCancer, MDAX, MetaSUB, Migration, Minden, myeloma, Natera, NeuMoDx, Nevada, Nonemployee, novo, orderly, PACT, perpetual, Pfizer, posed, possession, Postbank, postmarket, PowerSoil, predetermined, ProstateCancerPanel, push, quicker, ramp, Reaping, reinforcing, reorganization, repetitive, SRL, straddle, stranded, synchronized, syndromic, tailored, TMB, tradable, UCP, ultrasensitive, UMI, unbilled, unclear, upfront, upward, vendor, VIE, whichever, won
Removed:
Abbott, adjunctive, AdnaGen, attractive, branch, BreastCancer, broaden, broker, called, cancelled, Carlsbad, cell, certifying, client, collectability, compact, consigned, consignment, consumption, curated, deliverable, demanding, digit, discontinuation, displacing, downstream, earliest, easy, EMD, emergency, equivocal, era, escrow, ESEQuant, expertly, expression, feedback, FIFO, Fisher, foregoing, Franklin, glucose, greatly, Grundstuecksverwaltungsgesellschaft, guaranteed, headcount, headwind, Hong, house, includable, Ingenuity, Inhibitor, IPO, Kong, Korean, LDT, lengthy, liquidated, livestock, loaned, Malaysia, Marseille, mbH, Merck, Millipore, Modaplex, neglect, older, optical, Pap, partly, perjury, persuasive, petition, plate, portable, preacquisition, Promega, pure, pursuing, QIAgility, QIAxcel, ratably, reagent, recover, relapse, remote, risky, Roche, roll, sharply, side, standardize, subdivision, succeed, surpassing, surtax, synergistic, Taiwan, tapping, tariff, Thermo, tube, twenty, unconsolidated, undisclosed, unprecedented, unsubordinated, urge, variant, visualizing, VSOE, warehouse, water
Financial reports
20-F
2018 FY
Annual report (foreign)
6 Mar 19
20-F
2017 FY
Annual report (foreign)
6 Mar 18
20-F
2016 FY
Annual report (foreign)
6 Mar 17
20-F
2015 FY
Annual report (foreign)
29 Feb 16
20-F
2014 FY
Annual report (foreign)
2 Mar 15
20-F
2013 FY
Annual report (foreign)
3 Mar 14
20-F
2012 FY
Annual report (foreign)
4 Mar 13
20-F
2011 FY
Annual report (foreign)
27 Mar 12
20-F
2010 FY
Annual report (foreign)
21 Mar 11
20-F
2009 FY
Annual report (foreign)
17 Mar 10
Current reports
6-K
Current report (foreign)
8 May 19
6-K
Current report (foreign)
8 May 19
6-K
Current report (foreign)
5 Feb 19
6-K
Current report (foreign)
7 Nov 18
6-K
Current report (foreign)
7 Nov 18
6-K
Current report (foreign)
31 Oct 18
6-K
Current report (foreign)
31 Oct 18
6-K
Current report (foreign)
31 Oct 18
6-K
Current report (foreign)
31 Jul 18
6-K
Current report (foreign)
31 Jul 18
Registration and prospectus
25
Voluntary exchange delisting
8 Jan 18
8-A12B
Registration of securities on exchange
20 Dec 17
S-8
Registration of securities for employees
5 May 17
S-8
Registration of securities for employees
2 Apr 15
S-8
Registration of securities for employees
17 Nov 11
424B5
Prospectus supplement for primary offering
25 Sep 09
424B5
Prospectus supplement for primary offering
23 Sep 09
F-3ASR
Automatic shelf registration (foreign)
22 Sep 09
424B3
Prospectus supplement
7 Aug 07
S-8
Registration of securities for employees
7 Aug 07
Proxies
No filings
Other
SD
Conflict minerals disclosure
8 May 19
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
6 Mar 19
SD
Conflict minerals disclosure
17 May 18
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
6 Mar 18
SD
Conflict minerals disclosure
24 Apr 17
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
6 Mar 17
UPLOAD
Letter from SEC
16 Aug 16
CORRESP
Correspondence with SEC
8 Aug 16
UPLOAD
Letter from SEC
28 Jul 16
SD
Conflict minerals disclosure
25 May 16